Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) traded down 0% during mid-day trading on Wednesday. The company traded as low as $0.58 and last traded at $0.5810. Approximately 33,509 shares traded hands during trading, a decline of 39% from the average session volume of 55,045 shares. The stock had previously closed at $0.5811.
Retractable Technologies Price Performance
The company’s 50 day moving average price is $0.68 and its 200 day moving average price is $0.68. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The company has a market cap of $17.40 million, a price-to-earnings ratio of -1.08 and a beta of 1.20.
Institutional Trading of Retractable Technologies
A hedge fund recently bought a new stake in Retractable Technologies stock. BlackRock Inc. bought a new stake in Retractable Technologies, Inc. (NYSE:RVP – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 241,121 shares of the company’s stock, valued at approximately $174,000. BlackRock Inc. owned about 0.81% of Retractable Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 7.58% of the company’s stock.
Retractable Technologies Company Profile
Retractable Technologies, Inc (NYSE:RVP) develops, manufactures and markets medical devices designed to reduce needlestick injuries and improve healthcare worker safety. The company’s products are primarily used for the injection and withdrawal of fluids in clinical and laboratory settings.
Its product portfolio includes VanishPoint safety syringes and blood collection devices, retractable needles, and other safety-focused injection products. The company also offers EasyPoint needles and related devices for applications such as medication administration, blood collection and insulin delivery.
Recommended Stories
- Five stocks we like better than Retractable Technologies
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
